Autologous stem-cell transplantation improves survival in scleroderma patients: The SCOT trial – 2 Minute Medicine
2 Minute Medicine |
Autologous stem–cell transplantation improves survival in scleroderma patients: The SCOT trial
2 Minute Medicine Prior studies assessing autologous hematopoietic stem–cell transplantation indicated improved pulmonary function, but uncertainty surrounding long-term results and safety data has not led to widespread use of this treatment in clinical practice. The … |
